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Abstract. The objective of this study was to determine the quantitative intravascular ultrasound
(IVUS) and angiographic changes that occur during 1 year follow-up after renal artery stent
placement, given that restenosis continues to be a limitation of renal artery stent placement. 38
consecutive patients with symptomatic renal artery stenosis treated with Palmaz stent placement
were studied prospectively. IVUS and angiography were performed at the time of stent placement
and at 1 year follow-up. At follow-up, angiographic restenosis was seen in 14% of patients. The
lumen area in the stent, seen with IVUS, was significantly decreased from 24¡5.6 mm2 to
17¡5.6 mm2 (p,0.001) solely due to plaque accumulation. The distal main renal artery showed a
significant decrease in lumen area owing to a significant vessel area decrease from 39¡14.0 mm2
to 29¡9.3 mm2 (p,0.001) without plaque accumulation. Angiographic analysis confirmed this
reduction in luminal diameter and showed that the distal renal artery diameter at follow-up was
significantly smaller than before stent placement (86¡23.0% vs 104¡23.9% of the contralateral
renal artery diameter; p50.003). Besides plaque accumulation in the stent, unexplained shrinkage
of the distal main renal artery was evidenced with IVUS and angiography 1 year following stent
placement.
Stent placement is in common use for the revas-
cularization of renal artery stenosis (RAS). However,
restenosis after renal artery stent placement conti-
nues to be a problem, with reported restenosis
rates in up to 39% of patients at 8 months follow-
up [1]. In order to characterize the restenotic
process we used intravascular ultrasound (IVUS)
as an adjunct to standard angiography, because
IVUS provides accurate data on vessel and plaque
dimensions that allows monitoring of changes
that occur over time in the treated vessel.
The aim of the present study was to determine
the quantitative IVUS and angiographic changes
in the renal artery seen at 1 year follow-up in a
series of consecutive patients who underwent renal
artery stenting for atherosclerotic RAS.
Methods
Patients
Between September 1996 and December 1998,
41 consecutive patients (27 men, 14 women; aged
60¡9 years (mean¡standard deviation unless
stated)) presenting with symptomatic RAS of
¢50% diameter stenosis were treated with stent
placement. One patient underwent stenting of
both renal arteries on two separate occasions,
therefore, a total of 42 renal arteries were treated.
Patients had renal function impairment (serum
creatinine¢110 mmol l21; n526) and/or drug resis-
tant hypertension, defined as a diastolic blood
pressure¢95 mmHg while receiving two ‘‘defined
daily doses’’ of antihypertensive drug treatment
(n526). The defined daily dose is the assumed
average maintenance doses of the individual drugs
based on its main indication in adults [2]. Patients
were studied with IVUS and angiography before
any intervention was performed and immediately
after stent placement. At 1 year follow-up, IVUS
and angiographic examinations were repeated.
The local Committee on Human Research appro-
ved the investigation. Written informed consent
was obtained from all patients.
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Procedure
Pre-intervention digital subtraction angiograms
were obtained using aortic-flush injections. The
stenosis was then crossed with a 5 F selective
catheter. Pre-intervention IVUS imaging was
performed over a 0.020 inch flexible tip guide-
wire (Terumo, Tokyo, Japan). The lesion was
pre-dilated with an angioplasty balloon 5 mm or
6 mm in diameter. A Palmaz stent (Johnson &
Johnson Interventional Systems, New York, NY)
was then placed (p104 (10.4 mm stent length),
p154 (15.4 mm) or p204 (20.4 mm) stents). Stent
placement was considered technically successful
when post-procedural IVUS and angiography
showed complete stent–vessel wall apposition,
complete lesion covering and a ,20% residual
diameter stenosis [3]. When necessary, additional
stent dilatation was performed using a 6 mm or
7 mm balloon. During the procedure, patients
received 5000 IU of heparin, after which heparin
infusion was continued for 48 h (20 000–30 000 IU
day21). Oral acetylsalicylic acid (100 mg daily)
was started at the day of the procedure and
continued during the entire follow-up period.
IVUS analysis
For IVUS examination, a 30 MHz mechanical
imaging system (Princeps, Endosonics, Rijswijk,
The Netherlands) [4] with 4.3 F catheters was
used. The IVUS catheter was positioned distally
from the stenosis in a second-order renal artery
branch. Real-time cross-sectional images of the
entire main renal artery, obtained during slow
pullback of the IVUS catheter, were displayed on
a monitor and stored on a super video home
system. For the purpose of this study quantitative
analysis was performed. Before intervention, a
reference cross-section of the distal renal artery
just proximal to the first major side-branch was
analyzed. In addition, after IVUS and successful
angiographic stent placement, and at 1 year follow-
up, three cross-sections selected from the IVUS
examinations were analyzed; one cross-section
at the most stenotic site in the stent and two
reference cross-sections in the distal renal artery
(one just distal to the stent and another just
proximal to the firstmajor side-branch). Quantitative
measurements of IVUS cross-sections were per-
formed using a digital video analyser system [5].
Analysis included assessment of the lumen area
(LA) (the area encompassed by the inner intimal
surface), the native vessel area (VA) (the area
bounded by the external elastic lamina), the stent
area (SA) (the area encompassed by the stent
struts), and the plaque area (PLA) (calculated
as VA2LA, or SA2LA for the stented and
non-stented cross-sections, respectively). All IVUS
measurements were performed by two indepen-
dent observers. Mean values of the two observers
are given.
Angiographic analysis
Angiographic in-stent restenosis at 1 year follow-
up was defined as a ¢50% diameter reduction in
the stent, compared with the distal main renal
artery. After stent placement, and at follow-up,
angiographic lumen diameter of the ipsilateral
and contralateral main renal arteries (before the
first major side-branch) and of major intrarenal
branches were quantified in an absolute sense by
relating the measurements to the known length of
the Palmaz stent. In addition, the angiographic
diameter of the affected renal artery distal to the
lesion before and immediately after stent place-
ment, and at follow-up, was expressed as a
percentage of the diameter of the contralateral
renal artery.
Statistical analysis
Observer variability for IVUS measurements
was analyzed using regression analysis and Bland–
Altman’s method. Student’s t-test for paired obser-
vations was used to test for significant differences
betweenmeasurements at baseline, after stent place-
ment and at follow-up. A p-value ¡0.05 was con-
sidered statistically significant.
Results
Stent placement was technically successful in 39
renal arteries of 38 patients. At baseline, IVUS
was performed in 14 patients and after stent
placement in 38 patients. In the remaining patients,
the IVUS catheter could not pass the stenosis,
or the interventionist refrained from using IVUS
before stent placement. Follow-up (12.2¡2.8
months (mean¡standard deviation) IVUS ima-
ging was completed in 30 renal arteries of 29
patients. In one patient the IVUS catheter could
not pass the stent. Angiography before and after
stent placement was obtained in all 38 patients
and in 28 patients at follow-up. In two patients
with poor renal function, angiography was not
performed. In one of these two patients, only
IVUS was performed. Eight patients were lost to
follow-up owing to dialysis (n53), patient refusal
(n54) and patient death (n51). Stent patency
was demonstrated in the latter patients during
follow-up with spiral CT or captopril renography.
Angiographic in-stent restenosis was encountered
in 4 of 28 patients (14%) and these patients
underwent additional balloon angioplasty.
LA in the stent decreased significantly during
follow-up from 24¡5.6 mm2 to 17¡5.6 mm2
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(p,0.001) (Table 1), which was entirely owing to
an increase of plaque area in the stent. Stent area
and diameter remained unchanged. In the renal
artery distal to the stent, LA decreased signifi-
cantly owing to a decrease in vessel area
(39¡14.0 mm2 immediately after stent placement
to 29¡9.3 mm2 at follow-up; p,0.001) without
plaque accumulation (Figure 1). Of all reference
cross-sections after stent placement, 42 showed
VA decrease, 11 showed a less than 10% change
and 7 showed an enlargement. Of 10 patients with
matched pre-intervention and follow-up IVUS
data, the reference vessel area at follow-up was
smaller (.10%) than prior to intervention in five
patients, had less than 10% change in two
patients, and was larger (.10%) in three patients.
There was good observer agreement for IVUS
measurements, with a high correlation coefficient
(r) (r50.978; observer 25(0.996observer 1)20.01)
and an overall coefficient of variation of 6.3%.
Similar to IVUS measurements, quantitative
angiographic measurements of the distal main
renal artery showed a significantly decreased
diameter at 1 year follow-up when compared
with diameters measured immediately after stent
placement (p,0.001) (Table 2). In contrast, the
diameters of the intrarenal branches and the
contralateral renal artery remained unchanged.
Whereas immediately after stent placement there
was no significant difference between the diameter
of the ipsilateral and contralateral renal arteries,
the treated renal artery at follow-up was signifi-
cantly smaller than the contralateral artery
(5.0¡1.4 mm vs 5.8¡1.2 mm, respectively;
p50.004). The distal renal artery diameter at
follow-up was also significantly smaller than
before stent placement (86¡5.1% (mean¡stan-
dard error of the mean) vs 104¡5.3% of the
contralateral renal artery diameter; p50.003)
(Figure 2).
Figure 1. Intravascular ultrasound
and angiographic images (a, c) after
stent placement and (b, d) at 1 year
follow-up. The inner contour of
the intravascular images presents the
lumen area, the outer contour the
stent or vessel area. At follow-up,
plaque accumulation was evidenced
in the stent (b), whereas the distal
reference cross-section showed shrink-
age without plaque accumulation (d).
Table 1. Intravascular ultrasound measurements in 30
renal arteries obtained immediately after stent place-
ment and at 1 year follow-up. Cross-sections were
analyzed at the most stenotic site in the stent and at









Lumen area 24¡5.6 17¡5.6 ,0.001
Stent area 24¡5.6 25¡5.5 NS
Plaque area 0 7¡4.0 ,0.001
Main renal artery
Lumen area 29¡11.4 20¡7.3 ,0.001
Vessel area 39¡14.0 29¡9.3 ,0.001
Plaque area 10¡4.7 10¡4.4 NS
N.B. Values are mean¡standard deviation.
NS, not significant.
Table 2. Angiographic measurements obtained imme-









Main renal artery 6.5¡1.4 5.0¡1.4 ,0.001
Intrarenal branch 2.7¡1.0 2.8¡0.7 NS
Contralateral renal
artery
Main renal artery 6.1¡1.3 5.8¡1.2 NS
Intrarenal branch 3.0¡1.0 2.9¡0.8 NS
N.B. Values are mean¡standard deviation.
NS, not significant.
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Discussion
In the present study we quantified the change in
vessel dimensions of the renal arteries during the
first year after stent placement for atherosclerotic
RAS. At 1 year follow-up there was a significant
decrease in LA in the stent, which was solely
owing to plaque accumulation. There was no
evidence for recoil of the Palmaz stent, which
agrees with findings reported in coronary stents
[6]. However, the typical plaque accumulation at
the stent edges, as reported in coronary stents [7],
was not seen in renal stents. The in-stent resten-
osis rate of 14% in the present study was similar
to the 19% restenosis rate reported in a series of
100 renal stent patients by White et al [8]. It
should be acknowledged that the favorable re-
stenosis rate in the present study may be related
to the use of IVUS during the stent placement
procedure; previously we showed that in 33% of
patients, additional dilatation or stent placement
was warranted to achieve accurate stent place-
ment [3]. However, a randomized study is required
to assess the true beneficial role of IVUS on long-
term stent patency.
A remarkable finding in the present study was
shrinkage of the affected distal main renal artery
without plaque accumulation at follow-up. The
absolute VA as measured with IVUS decreased by
25%. This shrinkage was also evidenced with
angiography and was limited to the main renal
artery distal to the stent. At angiography the
diameter of the affected main renal artery, com-
pared with the contralateral renal artery, at follow-
up was significantly smaller than immediately
before and after stent placement. To the best of
our knowledge, this shrinkage has not been
described before. At present, there is no clear
explanation for this phenomenon and the follow-
ing discussion is therefore speculative.
A potential explanation for shrinkage may be
found in the change of blood flow owing to stent
placement. Stent placement is reported to cause
an increase in blood flow in the distal main renal
artery [9]. Increased blood flow will increase the
wall shear stress [wall shear stress546blood
viscosity6(flow/pr3)]. Increased wall shear stress will
induce an adaptation process of the vessel wall
mediated by nitric oxide [10], which may result in
vessel dilatation both immediately after stent
placement and at follow-up. After stent placement
this agreed both with data previously presented by
others [8] and with our previously presented
findings that pre-dilatation and stent placement
resulted in enlargement of the distal renal artery
[3]. At follow-up, however, shrinkage of the distal
renal artery instead of dilatation was experienced.
Converseley, long-term data on blood flow after
stent placement are scarce and it is not clear
whether renal artery stenting results in long-
standing flow improvement. Since a kidney regu-
lates blood flow by changing vascular resistance,
an initial increase of renal vessel dimensions may
be explained as a lack of immediate adaptation to
increased blood flow. In the long-term the kidney
may have adapted its vascular resistance, which
might have resulted in a decrease of renal blood
flow thereby decreasing renal vessel dimensions.
The decrease in renal vessel diameter may also
reflect an active shrinkage process. This may be due
to iatrogenic damage to the renal artery segment
immediately distal to the stent during stent place-
ment. It has been previously reported that such
stretching of the vessel wall in coronary arteries
may cause injury with fragmentation of the internal
elastic lamina, resulting in neointimal thickening
at follow-up [11]. In the present study, however,
shrinkage occurred without neointimal thicken-
ing; also it occurred in the distal renal artery
segment, unlikely to be touched by the dilatation
balloon.
Aside from the issue of the pathophysiologic
mechanism underlying the encountered shrinkage,
the data raise some concern over the clinical value
of stent placement for RAS. Should shrinkage be
progressive over time, this itself might lead to
stenosis and could make stent placement a less
useful treatment for RAS in the long-term. This
should be determined in future studies using a
longer follow-up period. In addition, the possible
(patho)physiological mechanism underlying the des-
cribed phenomenon should be further investigated.
Aside from measurements of renal blood flow
before and immediately after stent placement, and
Figure 2. Renal vessel diameter (RVD) of the affected
side before and after stent placement and at follow-
up, expressed as percentage of the contralateral artery
diameter. The relative diameter at follow-up was
significantly smaller than pre-interventional values.
Mean¡standard error of the mean are indicated.
T C Gill-Leertouwer, E J Gussenhoven, J Deinum et al
882 The British Journal of Radiology, November 2002
at follow-up, it would be of interest to study
whether shrinkage is associated with endothelial
dysfunction or is a more generalized reflection of
vascular pathology. This may be determined by
measuring the vasodilative capacity of the distal
renal artery after infusion of endothelial-dependent
and independent substances, e.g. by using Doppler
flow-wires.
In conclusion, renal artery stent placement
resulted in shrinkage of the distal main renal
artery at 1 year follow-up. The explanation for
this phenomenon, evidenced both by IVUS and
angiography, is at present unknown and should
be further investigated.
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